Products

HeartKey® Rhythm
B-Secur Limited
Cardiology AI
HeartKey® Rhythm is an FDA-cleared AI ECG software library by B-Secur Limited, designed to enhance the accuracy and efficiency of cardiac monitoring in ambulatory settings. It uses advanced signal processing to reduce noise and provide high-quality ECG data for clinical decision-making.

See all 1 product →

About B-Secur

B-Secur is a leading healthcare AI company specializing in advanced biosensing technology, particularly focused on enhancing heart health through sophisticated electrocardiogram (ECG) solutions. Their core offering, HeartKey®, is an FDA-cleared suite of powerful ECG algorithms and analytics designed to deliver medical-grade ECG data and actionable wellness insights. This technology significantly improves signal clarity by reducing noise and artifacts, a critical challenge in remote cardiac monitoring systems, thereby facilitating more accurate interpretation and streamlining clinical workflows for healthcare professionals.

HeartKey® Rhythm, one of their key solutions, includes highly accurate rhythm detection algorithms and signal quality indicators, empowering clinicians with greater confidence in diagnosing actionable cardiac conditions. B-Secur’s solutions are versatile, enabling seamless integration into a wide array of devices such as wearables, Holter monitors, ECG patches, and Mobile Cardiac Telemetry (MCT) systems, with deployment options for both on-device and cloud-based applications. The company’s mission is to drive preventative and proactive health management by providing clearer, more precise insights into heart health for clinicians, as well as for users of consumer and medical wearable devices and platforms globally.

B-Secur’s extensive research and development efforts have amassed over two million hours of data and analyzed more than seven billion heartbeats, contributing to significant advancements in noise reduction and signal fidelity in ECG technology. They partner with leading technology companies to embed their HeartKey® algorithms, supporting the development of next-generation medical and consumer health technologies and addressing the growing need for scalable solutions in cardiac care amidst rising cardiovascular disease prevalence and physician shortages.

Focus Areas

Biosensing technology ECG algorithms Heart health monitoring Preventative health management Proactive health management User identification Arrhythmia detection Signal conditioning Remote patient monitoring Wearables Medical devices

Business Intelligence

Key InvestorsOrlando Health Ventures, UK FF Nominees, Rudolf Wolff, First Capital Ventures, British Business Bank, Clarendon Fund Managers, Kernel Capital, Accelerated Digital Ventures (ADV), Wharton Asset Management
PartnershipsBiotricity, Orlando Health, WHOOP, FIRMINIQ, Wellvii
TechnologyHeartKey® software library, ECG algorithms, On-device applications, Cloud applications, Signal processing engine, AI-powered electrocardiogram (ECG) solutions, Device-neutral platform
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Biosensing Technology
B-Secur's proprietary HeartKeyu00ae technology is at the forefront of biosensing, enabling a new level of care in health and wellness markets.
ECG Algorithms & Analytics
HeartKeyu00ae offers a suite of powerful, FDA 510(k) cleared ECG algorithms and analytics, including HeartKeyu00ae Rhythm, designed for high clinical accuracy and efficiency.
Heart Health Monitoring
Revolutionizing cardiac health monitoring by significantly reducing noise in ECG data, leading to enhanced interpretation and improved clinical workflows with clinical-grade accuracy.
Preventative & Proactive Health Management
Enables timely, efficient, and preventative care by providing high-quality ECG data and actionable wellness insights, addressing the rising prevalence of cardiovascular diseases.
User Identification
HeartKeyu00ae's User ID leverages individual ECG patterns to personalize and protect physiological data, enhancing security and reducing data corruption risks.
Arrhythmia Detection
FDA-cleared algorithms within HeartKeyu00ae Rhythm are capable of detecting and classifying cardiac rhythms such as normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia.
Signal Conditioning
Intelligent and adaptive signal conditioning technology ensures high-quality ECG signals, even from dry electrodes in noisy environments, forming the foundation for accurate algorithm performance.
Remote Patient Monitoring
Enhances remote monitoring capabilities by processing ECGs in challenging ambulatory environments, seamlessly integrating with various medical devices and wearables.
Wearables & Medical Devices
HeartKeyu00ae is designed for facile integration into a wide range of devices, including smartwatches, ECG patches, Holter monitors, and Mobile Cardiac Telemetry (MCT) systems.
Physician Tip

B-Secur's HeartKeyu00ae technology stands out for physicians due to its FDA-cleared, clinical-grade ECG algorithms that significantly reduce signal noise, leading to faster and more accurate diagnoses. This improved signal clarity minimizes the need for repeat testing and streamlines clinical workflows, allowing for more confident interpretation of data and prioritization of actionable cardiac conditions. The ability to obtain high-quality ECG data from remote and ambulatory settings, including consumer wearables, supports proactive and preventative care, which is crucial in managing cardiovascular diseases and addressing the shortage of cardiac specialists. Furthermore, the secure and flexible deployment options, such as Docker containers, ensure patient data privacy and control.

B-Secur's HeartKeyu00ae is offered as a software library with APIs, designed for flexible integration into existing platforms and devices, either on-device or via the cloud. They collaborate with semiconductor companies and offer an ECG Development Kit to accelerate integration for device manufacturers. The technology is device-agnostic and cloud-enabled, supporting seamless data integration from various smart devices into regulated care pathways.

Products by B-Secur

1 product in the directory

HeartKey® Rhythm
B-Secur Limited
Cardiology AI
HeartKey® Rhythm is an FDA-cleared AI ECG software library by B-Secur Limited, designed to enhance the accuracy and efficiency of cardiac monitoring in ambulatory settings. It uses advanced signal processing to reduce noise and provide high-quality ECG data for clinical decision-making.

Reviews & Opinions

No web reviews on file yet for B-Secur. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about B-Secur.

Loading videos...

Videos load interactively. If none appear, search YouTube for B-Secur →

View all on YouTube

Press & Coverage

B-Secur
B-Secur Elevates Proactive, Efficient Cardiac Care with FDA-Cleared HeartKeyu00ae Rhythm Solution
B-Secur announced the FDA clearance and launch of HeartKeyu00ae Rhythm, a suite of ECG algorithms and analytics designed to enhance clinical confidence and improve outcomes for cardiac patients. This marks their second FDA clearance in four years.
2024-09
B-Secur
B-Secur and FIRMINIQ Join Forces to Transform Cardiovascular Health Management
B-Secur and FIRMINIQ announced a strategic partnership to transform cardiovascular health management globally by integrating B-Secur's ECG software with FIRMINIQ's connected health solutions. This collaboration aims to empower healthcare providers in the prevention, diagnosis, and management of heart-related chronic diseases.
2024-08
B-Secur
Cardiac care solutions aren't keeping pace with a significant growth in need and ecosystem complexity
This article discusses the growing challenge of cardiovascular disease and the need for advanced signal processing to improve the accuracy of ECG data from wearable devices. It highlights how cleaning up ECG signals can make sensors and devices more effective for proactive, preventative tools.
2024-09
B-Secur
Accurate Identification of Actionable ECG Data Using a Signal Quality Assessment Algorithm
This publication focuses on an algorithm developed by B-Secur for accurately identifying actionable ECG data through signal quality assessment. It is categorized under publications on their website.
2024-09
B-Secur
Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform
Biotricity and B-Secur are expanding their joint cardiac monitoring platform to support ECG data from consumer wearables, aiming to bring clinical-grade heart monitoring to devices like smartwatches and rings. This collaboration leverages B-Secur's FDA-cleared HeartKeyu00ae ECG algorithms for medical-grade accuracy.
2025-09
B-Secur
Performance of Embedded ECG Analysis Software for Atrial Fibrillation Detection on a Wrist Wearable in a Clinical Cohort
This publication details a study on the performance of embedded ECG analysis software for atrial fibrillation detection in a wrist wearable within a clinical cohort. It is listed in B-Secur's publications archive.
2025-03
B-Secur
B-Secur Raises $12 Million in New Funding
B-Secur raised US$12 million in new funding, led by First Capital Ventures, to accelerate its commercial expansion in the U.S. consumer and medical industries and further develop its FDA-cleared HeartKeyu00ae algorithms.
2021-11
Business Wire
B-Secur receives FDA Regulatory Clearance For Its HeartKeyu00ae EKG/ECG Technology
B-Secur announced it received U.S. Food and Drug Administration (FDA) 510(K) clearance for its HeartKeyu00ae software library, enabling its ECG algorithms for user identification, health, and wellness to be implemented across various devices.
2021-02

Frequently Asked Questions

B-Secur's core biosensing technology is HeartKeyu00ae, a suite of proprietary ECG algorithms and analytics. It significantly enhances signal clarity by reducing noise in ECG data, delivering clinical-grade accuracy for improved interpretation and streamlined clinical workflows.
B-Secur's HeartKeyu00ae software library has received FDA 510(k) clearance, including for its HeartKeyu00ae Rhythm product, affirming its adherence to stringent safety and efficacy requirements for medical device software. Additionally, B-Secur is ISO 13485:2016 certified, demonstrating their commitment to quality management systems for medical devices.
B-Secur's HeartKeyu00ae technology is designed to enable preventative and proactive health management by providing accurate, medical-grade ECG data from various devices, including ambulatory ECG systems and consumer wearables. This allows clinicians to monitor patients remotely, detect actionable cardiac conditions like arrhythmias earlier, and make more informed decisions for timely intervention.
Yes, B-Secur's HeartKeyu00ae algorithms are capable of analyzing incoming ECG signals to detect various arrhythmias, including normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia. Their intelligent and adaptive signal conditioning technology is crucial for this accuracy, as it filters out noise and interference to ensure high-quality ECG detection in real-time, even from dry electrodes.
B-Secur partners with medical device manufacturers, technology companies, and healthcare organizations like Orlando Health, FIRMINIQ, and Biotricity. They support these partners by integrating their FDA-cleared ECG algorithms into various devices and platforms, offering professional services for design optimization, clinical validation, and regulatory guidance to accelerate time to market for next-generation medical and consumer devices.
Yes, HeartKeyu00ae includes an ECG User ID feature that utilizes an individual's unique heartbeat for user identification. This capability helps personalize and protect physiological data, reducing the risk of data corruption and enabling more refined analytics while maintaining data security.
While specific pricing details are not publicly disclosed, B-Secur offers comprehensive professional services to support integration, including expertise in hardware, software, material science, and regulatory strategy. This aims to reduce development time and costs for partners, ensuring efficient deployment and ongoing support for their medical-grade biosensing technology.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.